CAPTRUST Financial Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Sell |
|
|||||
|
2025
Q1 | $15.9K | Sell |
|
|||||
|
2024
Q4 | $44K | Sell |
|
|||||
|
2024
Q3 | $78.9K | Hold |
|
|||||
|
2024
Q2 | $81K | Sell |
|
|||||
|
2024
Q1 | $177K | Buy |
|
|||||
|
2023
Q4 | $13.7K | Sell |
|
|||||
|
2023
Q3 | $17.1K | Hold |
|
|||||
|
2023
Q2 | $20.3K | Buy |
|
|||||
|
2023
Q1 | $23.6K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $21K | Buy |
|
|||||
|
2022
Q2 | $8K | Hold |
|
|||||
|
2022
Q1 | $10K | Buy |
|
|||||
|
2021
Q4 | $4K | Hold |
|
|||||
|
2021
Q3 | $5K | Hold |
|
|||||
|
2021
Q2 | $4K | Hold |
|
|||||
|
2021
Q1 | $5K | Buy |
|